Intra-Cellular Therapies stock surges 20% post Study 501 results, Mizuho raises PT April 16, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Turnstone Biologics announces board member resignation Back: All Posts Next:JPMorgan sees 'material downside risk' for Tesla stock despite YTD drop